ArticleNeurosurgery2020

Diffusion Magnetic Resonance Imaging Phenotypes Predict Overall Survival Benefit From Bevacizumab or Surgery in Recurrent Glioblastoma With Large Tumor Burden.

Kunal S Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.